z-logo
open-access-imgOpen Access
6 Factor VIII Concentrates, Factor VIII/von Willebrand Factor Concentrates, Factor IX Concentrates, Activated Prothrombin Complex Concentrates
Author(s) -
Peter Schlenke,
Walter Sibrowski
Publication year - 2009
Publication title -
transfusion medicine and hemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.971
H-Index - 39
eISSN - 1660-3818
pISSN - 1660-3796
DOI - 10.1159/000268062
Subject(s) - factor ix , prothrombin complex , prothrombin complex concentrate , von willebrand factor , blood coagulation factors , medicine , factor (programming language) , coagulation , chemistry , platelet , warfarin , computer science , atrial fibrillation , programming language
6.5 Range of Application, Dosage, Mode of Administration 6.5.1 General Information 6.5.2 Indications for Replacement Therapy Using Factor Concentrates 6.5.3 Dosage, Mode of Administration 6.5.3.1 Replacement in Children with Hemophilia A, B or von Willebrand Syndrome 6.5.3.2 Replacement in Adults with Hemophilia A, B or von Willebrand Syndrome 6.5.3.3 Indications and Recommended Doses for Treating Patients with Factor VIII Inhibitors in Hemophilia A 6.5.4 Absolute and Relative Contraindications

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom